# Study to Assess GW642444 in Asthma Patients

> **NCT00381667** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 14 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GW642444M
- **DRUG:** GW642444H
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00381667
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00381667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00381667, "Study to Assess GW642444 in Asthma Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00381667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*